Know Cancer

or
forgot password
  • cancer clinical trials in los angeles, CA

  • Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma
    USC/Norris Comprehensive Cancer Center and Hospital

    Trial Locations
    USC/Norris Comprehensive Cancer Center and Hospital
    UCLA Clinical AIDS Research and Education (CARE) Center
    Lymphoma
    Rituximab Plus CHOP With Sargramostim in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma
    USC Norris Comprehensive Cancer Center
    Los Angeles, California 90089
    Diffuse, Large B-Cell, Lymphoma
    Safety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active Acromegaly
    Cedars Sinai Medical Center The Pituitary Center

    Trial Locations
    Cedars Sinai Medical Center The Pituitary Center
    UCLA/ University of California Los Angeles Division of Endocrinology
    Acromegaly
    Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
    University of Southern California

    Trial Locations
    University of Southern California
    Los Angeles County-USC Medical Center
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
    Efficacy and Safety of Concentration-controlled Everolimus to Eliminate or to Reduce Tacrolimus Compared to Tacrolimus in de Novo Liver Transplant Recipients
    Cedars-Sinai Medical Center

    Trial Locations
    Cedars-Sinai Medical Center
    UCLA
    University of Southern CA
    Liver Transplantation
    Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
    City of Hope National Medical Center

    Trial Locations
    City of Hope National Medical Center
    University of California - Los Angeles
    Aspergillosis, Invasive Fungal Infections
    Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer
    Kenneth J. Norris Jr. Comprehensive Cancer Center, Keck School of Medicine, University of Southern California
    Los Angeles, California 90033
    Bladder Cancer
    N2004-03: Intravenous Fenretinide in Treating Young Patients With Recurrent or Resistant Neuroblastoma
    Childrens Hospital Los Angeles
    Los Angeles, California 90027
    Neuroblastoma
    Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant Glioma
    University of California at Los Angeles (UCLA )
    Los Angeles, California 90095
    Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Adult Mixed Glioma, Recurrent Adult Brain Tumor
    S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    USC/Norris Comprehensive Cancer Center and Hospital
    Los Angeles, California 90033-0804
    Lung Cancer
    Phase I Abraxane Weekly and Three Weekly Schedule With Vandetanib
    University of Southern California (U.S.C.)/ Norris Comprehensive Cancer Center
    Los Angeles, California 90033
    Solid Tumors
    Herbal Therapy for Treatment of Recurrent Prostate Cancer
    USC/Norris Comprehensive Cancer Center
    Los Angeles, California 90033-0800
    Prostate Cancer
    A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate Cancer
    Cedars-Sinai Medical Center
    Los Angeles, California 90048
    Prostatic Diseases, Genital Neoplasms, Male, Urogenital Neoplasms, Genital Diseases, Male, Adenocarcinoma, Prostatic Neoplasms, Neoplasms, Glandular and Epithelial, Carcinoma
    Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
    Childrens Hospital Los Angeles
    Los Angeles, California 90027
    Kidney Cancer, Leukemia, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Green Tea or Water in Treating Patients With Prostate Cancer Undergoing Surgery
    Veterans Affairs Medical Center - West Los Angeles

    Trial Locations
    Veterans Affairs Medical Center - West Los Angeles
    Jonsson Comprehensive Cancer Center at UCLA
    Prostate Cancer
    Safety Study of CALAA-01 to Treat Solid Tumor Cancers
    UCLA Jonsson Comprehensive Cancer Center
    Los Angeles, California 90095
    Cancer, Solid Tumor
    Pemetrexed and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer
    USC/Norris Comprehensive Cancer Center and Hospital
    Los Angeles, California 90033-0804
    Cervical Cancer
    Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
    Kaiser Permanente Los Angeles Medical Center

    Trial Locations
    Kaiser Permanente Los Angeles Medical Center
    Kaiser Permanente-West Los Angeles
    Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Kaiser Permanente-West Los Angeles
    Los Angeles, California 90034
    Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Study of XL184 (Cabozantinib) in Adults With Glioblastoma Multiforme
    University of California, Los Angeles
    Los Angeles, California
    Glioblastoma Multiforme
    Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer
    UCLA
    Los Angeles, California 90095
    Thyroid Cancer
    Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL)
    Children's Hospital of Los Angeles
    Los Angeles, California 90027
    Adenovirus Infection, EBV Infection
    Sipuleucel-T as Neoadjuvant Treatment in Prostate Cancer
    USC / Norris Comprehensive Cancer Center
    Los Angeles, California 90033
    Prostate Cancer
    Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study
    UCLA Medical Center

    Trial Locations
    UCLA Medical Center
    Univ of Southern California Comprehensive Cancer Center
    Secondary Acute Myeloid Leukemia (Secondary AML, sAML)
    Study of Adding AMG 479 to First Line Chemotherapy in Patients With Optimally Debulked Epithelial Ovarian Cancer
    Cedars-Sinai Medical Center

    Trial Locations
    Cedars-Sinai Medical Center
    UCLA
    Ovarian Neoplasms
    Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Children's Hospital Los Angeles

    Trial Locations
    Children's Hospital Los Angeles
    David Geffen School of Medicine at UCLA
    Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    BIBW 2992 (Afatinib) With or Without Daily Temozolomide in the Treatment of Patients With Recurrent Malignant Glioma
    1200.36.0014 Boehringer Ingelheim Investigational Site
    Los Angeles, California
    Glioma
    A Yoga and Wellness Program for Breast Cancer Survivors With Persistent Fatigue
    University of California, Cousins Center for PNI
    Los Angeles, California 90095
    Breast Cancer, Fatigue
    Multiple Ascending Dose (MDX1105-01)
    The Angeles Clinic & Research Institute
    Los Angeles, California 90404
    Cancer, Multiple Indications
    Gemcitabine and Erlotinib Before and After Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
    Kaiser Permanente Medical Center - Los Angeles
    Los Angeles, California 90027
    Pancreatic Cancer
    Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
    Cedars-Sinai Medical Center

    Trial Locations
    Cedars-Sinai Medical Center
    Children's Hospital Los Angeles
    David Geffen School of Medicine at UCLA
    Mattel Children's Hospital UCLA
    Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Angioimmunoblastic T-cell Lymphoma, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Grade III Lymphomatoid Granulomatosis, Childhood Immunoblastic Large Cell Lymphoma, Childhood Myelodysplastic Syndromes, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma, Essential Thrombocythemia, Extramedullary Plasmacytoma, Intraocular Lymphoma, Isolated Plasmacytoma of Bone, Juvenile Myelomonocytic Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Mast Cell Leukemia, Meningeal Chronic Myelogenous Leukemia, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Polycythemia Vera, Post-transplant Lymphoproliferative Disorder, Primary Central Nervous System Hodgkin Lymphoma, Primary Central Nervous System Non-Hodgkin Lymphoma, Primary Myelofibrosis, Primary Systemic Amyloidosis, Progressive Hairy Cell Leukemia, Initial Treatment, Prolymphocytic Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Stage 0 Chronic Lymphocytic Leukemia, Stage I Childhood Anaplastic Large Cell Lymphoma, Stage I Childhood Hodgkin Lymphoma, Stage I Childhood Large Cell Lymphoma, Stage I Childhood Lymphoblastic Lymphoma, Stage I Childhood Small Noncleaved Cell Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Multiple Myeloma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage II Childhood Anaplastic Large Cell Lymphoma, Stage II Childhood Hodgkin Lymphoma, Stage II Childhood Large Cell Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage II Childhood Small Noncleaved Cell Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Childhood Anaplastic Large Cell Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage III Childhood Small Noncleaved Cell Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Multiple Myeloma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage IV Childhood Anaplastic Large Cell Lymphoma, Stage IV Childhood Hodgkin Lymphoma, Stage IV Childhood Large Cell Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, Stage IV Childhood Small Noncleaved Cell Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, T-cell Large Granular Lymphocyte Leukemia, Unspecified Childhood Solid Tumor, Protocol Specific, Untreated Childhood Acute Lymphoblastic Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies, Untreated Hairy Cell Leukemia, Waldenström Macroglobulinemia